Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors

The blood-brain barrier (BBB) poses a major obstacle by preventing potential therapeutic agents from reaching their intended brain targets at sufficient concentrations. While transient disruption of the BBB has been used to enhance chemotherapeutic efficacy in treating brain tumors, limitations in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sajesh, Babu V., On, Ngoc H., Omar, Refaat, Alrushaid, Samaa, Kopec, Brian M., Wang, Wei-Guang, Sun, Han-Dong, Lillico, Ryan, Lakowski, Ted M., Siahaan, Teruna J., Davies, Neal M., Puno, Pema-Tenzin, Vanan, Magimairajan Issai, Miller, Donald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781504/
https://www.ncbi.nlm.nih.gov/pubmed/31533285
http://dx.doi.org/10.3390/pharmaceutics11090481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781504/
https://www.ncbi.nlm.nih.gov/pubmed/31533285
http://dx.doi.org/10.3390/pharmaceutics11090481

Ejemplares similares